Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.
Tobias TritschlerMarie-Eve MathieuLeslie SkeithMarc RodgerSaskia MiddeldorpTimothy BrightonPer Morten SandsetSusan R KahnDerek C AngusMarc BlondonMarc J BontenMarco CattaneoAndrea N EdgintonLennie P G DerdeMaria T DeSanchoJean-Luc DiehlEwan GoligherBernd JilmaPeter JüniPatrick R LawlerMarco MariettaJohn C MarshallColin McArthurCarlos Henrique MirandaTristan MiraultNuccia MoriciUsha PerepuChristian SchoergenhoferMichelle SholzbergAlex C SpyropoulosSteve A WebbRyan ZarychanskiStéphane ZuilyGrégoire Le Galnull nullPublished in: Journal of thrombosis and haemostasis : JTH (2020)
Several trials evaluate different dose regimens of anticoagulant interventions in hospitalized patients with COVID-19. Because these trials compete for sites and study participants, a collaborative effort is needed to complete trials faster, conduct pooled analyses and bring effective interventions to patients more quickly.